Medifast (MED) Revenue (2010 - 2026)

Medifast has reported Revenue for 17 years, with the latest figure at $76.0 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 34.29% year-over-year to $76.0 million; the trailing twelve-month figure through Mar 2026 stood at $346.1 million (down 36.31% YoY), and the FY2025 full-year result was $385.8 million, down 35.96% from the prior year.
• Revenue for Q1 2026 stood at $76.0 million, up from $75.1 million in the prior quarter.
• The five-year high for Revenue was $453.3 million in Q2 2022, with the low at $75.1 million in Q4 2025.
• Historically, Revenue has averaged $219.7 million across 5 years, with a median of $174.7 million in 2024.
• Annual changes were most pronounced in 2022 — Revenue grew 22.58% — and 2024, when it plunged 49.93%.
• Medifast's Revenue stood at $337.2 million in 2022, then slumped by 43.36% to $191.0 million in 2023, then slumped by 37.7% to $119.0 million in 2024, then plunged by 36.9% to $75.1 million in 2025, then grew by 1.26% to $76.0 million in 2026.
• The last three Revenue figures came in at $76.0 million (Q1 2026), $75.1 million (Q4 2025), and $89.4 million (Q3 2025), per Business Quant data.